Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | ||||||||
| Operating expenses | ||||||||
| Gross profit | ||||||||
| Administrative expenses | -39.31%-42.32M | 2.40%-74.06M | 15.53%-30.38M | 5.43%-75.88M | ---35.97M | -54.65%-80.24M | -169.11%-51.88M | ---19.28M |
| Research and development expenses | 16.61%-105.19M | 6.67%-215.12M | -23.27%-126.15M | 26.45%-230.49M | ---102.34M | -80.86%-313.36M | -121.01%-173.26M | ---78.39M |
| Special items of operating profit | 40.74%19.91M | 261.44%37.9M | 311.59%14.15M | 2,256.40%10.49M | ---6.69M | 194.68%445K | -99.15%-470K | ---236K |
| Operating profit | 10.38%-127.61M | 15.08%-251.27M | 1.80%-142.38M | 24.74%-295.88M | -144.99M | -74.26%-393.15M | -130.43%-225.61M | -97.91M |
| Financing cost | -53.59%-2.03M | -75.10%-3.02M | -67.89%-1.32M | -24.33%-1.73M | ---788K | -50.65%-1.39M | -510.60%-922K | ---151K |
| Special items of earning before tax | ---- | ---- | ---- | 81.60%-71.21M | ---71.21M | 25.91%-387.06M | -228.47%-522.43M | ---159.05M |
| Earning before tax | 9.79%-129.64M | 31.05%-254.3M | 33.77%-143.71M | 52.81%-368.81M | -216.99M | -4.36%-781.59M | -191.30%-748.96M | -257.11M |
| After-tax profit from continuing operations | 9.79%-129.64M | 31.05%-254.3M | 33.77%-143.71M | 52.81%-368.81M | -216.99M | -4.36%-781.59M | -191.30%-748.96M | -257.11M |
| Earning after tax | 9.79%-129.64M | 31.05%-254.3M | 33.77%-143.71M | 52.81%-368.81M | -216.99M | -4.36%-781.59M | -191.30%-748.96M | -257.11M |
| Profit attributable to shareholders | 9.79%-129.64M | 31.05%-254.3M | 33.77%-143.71M | 52.81%-368.81M | -216.99M | -4.36%-781.59M | -191.30%-748.96M | -257.11M |
| Basic earnings per share | 12.50%-0.35 | 57.74%-0.71 | 84.79%-0.4 | 83.51%-1.68 | -2.63 | 90.33%-10.19 | -191.26%-105.35 | -36.17 |
| Diluted earnings per share | 12.50%-0.35 | 57.74%-0.71 | 84.79%-0.4 | 83.51%-1.68 | -2.63 | 90.33%-10.19 | -191.26%-105.35 | -36.17 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.